Ivanka Galeva

Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

Diana Bilton, Tacjana Pressler, Isabelle Fajac et al. · Journal of Cystic Fibrosis · 2019 · 53 citations · Full text

Respiratory Infection, Infectious Respiratory Disease, Antimicrobial Chemotherapy +5

Tobramycin inhalation powder manufactured by improved process in cystic fibrosis: the randomized EDIT trial

Ivanka Galeva, Michael W. Konstan, Mark Higgins et al. · Current Medical Research and Opinion · 2013 · 44 citations · Full text

Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection

Diana Bilton, Isabelle Fajac, Tacjana Pressler et al. · Journal of Cystic Fibrosis · 2021 · 26 citations · Full text

Cystic Fibrosis Patients, Respiratory Infection, Pathology +2

One‐year safety and efficacy of tobramycin powder for inhalation in patients with cystic fibrosis

Michael W. Konstan, Patrick A. Flume, Ivanka Galeva et al. · Pediatric Pulmonology · 2015 · 19 citations

PHASE 3 EFFICACY AND SAFETY DATA FROM RANDOMIZED, MULTICENTER STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE) COMPARED WITH TOBI (R) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTION DUE TO PSEUDOMONAS AERUGINOSA

Diana Bilton, T. Pressler, F Isabelle et al. · Pediatric Pulmonology · 2013 · 18 citations

Antibiotic Adjuvant, Respiratory Infection, Antimicrobial Chemotherapy +5